BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

Shanghai Shanzhun Biotechnology Co., Ltd., established on 2015-07-16, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product production(No licensed chemical products);Sales of Class I Medical Devices;Instrument sales;electronics sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.

Novomics develops cancer treatment-linked diagnosis systems based on its expertise and knowledge in the field of molecular diagnosis. A significant strength of Novomics is its network of specialists and clinicians, as well as the knowledge gains made possible by technological advancements in the age of precision medicine. By embracing cutting-edge clinical, molecular biological, and academic achievements and forming close collaborative relationships with pharmaceutical companies and hospitals that are significant players in the medical industry.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis are available to patients, and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.

Based in Cologne, Germany, Sividon Diagnostics is a management buyout from Siemens Healthcare Diagnostics in Cologne. The aim of Sividon team of experienced scientists and managers was and still is, the quality of companion diagnostics in oncology to improve their products sustainably. So in the future treatment decisions could in cancer - especially breast cancer - will be further improved by an individualized, evidence-based diagnosis. In this way Sividon is also supported by an established international network of renowned experts. In addition to the many years of professional experience in molecular diagnostics, there are the extensive rights and to the year 2004 reaching back arrangements that characterize the team and Sividon.

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (personalized medicine), assess a patient's risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriad's discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: "There is no more exciting story in medical science." Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics, Inc..

Guizhou Lianke Weixin Technology Co., Ltd., established on 2009-04-21, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(Independent research and development of computer software products,to develop,Sales and Service;Computer System Integration Project;Intelligent building weak current system;Integrated wiring system;Computer Network Engineering Development,design and installation;Electronic communication and computer product design,to develop,Sales;Data storage and processing services;Information Technology Consulting Services;System application service;Internet Information Technology Services(In addition to Internet cafes);Intelligent product technology research and development and technology transfer;Sales:smart product,Medical Devices and Accessories;market research;Health Information Consultation;Business Consulting(Does not include investment,Financing and financial management,invest,Financing and wealth management consulting business,Do not engage in illegal fundraising,Illegal financial activities such as illegally absorbing public deposits,Do not engage in unapproved financial activities);Value-added Telecom Services;Electronic equipment rental.Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

WntResearch AB develops anti-metastatic therapies for the treatment of cancer patients. The company’s products include Foxy-5, a small peptide, which is in Phase I clinical stage development for reconstituting the effect of Wnt-5a in breast cancer cells; and Box-5 peptide that is in preclinical phase for antagonizing the effects of Wnt-5a. WntResearch AB was founded in 2007 and is based in Malmö, Sweden.

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

Beijing Institute of Genomics, Chinese Academy of Sciences (doing business as China Academy of Sciences Beijing Jiyinzu Research Laboratory) is a Chinese private company located in Beijing. The firm provides medical research services.